Rating History for AbCellera Biologics (ABCL) by Benchmark

More Stocks Rated by Benchmark | Latest Ratings for ABCL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/7/2026 Robert Wasserman Upgrade Buy
(Hold)		 11.00
(N/A)		 7.87
(5.80)		 -26.3% Details